Proteon Therapeutics Inc. Secures $38,000,000 Series B Financing

  • Feed Type
  • Date
    3/5/2009
  • Company Name
    Proteon Therapeutics Inc.
  • Mailing Address
    200 West Street Waltham, MA 02451
  • Company Description
    Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
  • Website
    http://www.proteontherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $38,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    Undisclosed
  • Venture Investor
    TVM Capital
  • Venture Investor
    Skyline Ventures
  • Venture Investor
    Prism VentureWorks
  • Venture Investor
    Intersouth Partners

By posting a comment, you agree to our terms and conditions.